Anna Turkina
- Hematology top 0.5%
- Genetics top 0.5%
- Rheumatology top 2%
- Oncology top 10%
- Molecular Biology
- Co-authors
- Dong‐Wook KimJörge E. CortesCarlo Gambacorti‐PasseriniHagop M. KantarjianH. Jean KhouryTim H. BrümmendorfEric LeipSteven Arkin
- Topics
- Chronic Myeloid Leukemia Treatments (119 papers)Chronic Lymphocytic Leukemia Research (80 papers)Eosinophilic Disorders and Syndromes (35 papers)
- Cited by
- HematologyGeneticsRheumatology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- RussiaUnited StatesGermany
In The Last Decade
Anna Turkina
114 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 68
- Hematology 1.2k
- Genetics 1.0k
- Rheumatology 544
- Oncology 296
- Molecular Biology 234
Countries citing papers authored by Anna Turkina
This map shows the geographic impact of Anna Turkina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Turkina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Turkina more than expected).
Fields of papers citing papers by Anna Turkina
This network shows the impact of papers produced by Anna Turkina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Turkina. The network helps show where Anna Turkina may publish in the future.
Co-authorship network of co-authors of Anna Turkina
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Turkina. A scholar is included among the top collaborators of Anna Turkina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Turkina. Anna Turkina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 26 | |
| 7 | 5 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 1 | |
| 11 | 2 | |
| 12 | 0 | |
| 13 | 3 | |
| 14 | 3 | |
| 15 | PHARMACOECONOMIC MODELLING OF TARGET THERAPY CHRONIC MYELOGENOUS LEUKEMIA: EARLY AND LATE SWITCHING | 1 |
| 16 | 2 | |
| 17 | 5 | |
| 18 | СИНХРОННЫЕ И МЕТАХРОННЫЕ МИЕЛОИДНЫЕ И ЛИМФОИДНЫЕ ОПУХОЛИ | 0 |
| 19 | 1 | |
| 20 | A rare complication of imatinib mesylate therapy: drug-induced pneumonitis | 1 |
About Anna Turkina
Anna Turkina is a scholar working on Hematology, Genetics and Rheumatology, having authored 134 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (119 papers), Chronic Lymphocytic Leukemia Research (80 papers) and Eosinophilic Disorders and Syndromes (35 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (1.0k citations) and Rheumatology (544 citations). Anna Turkina has collaborated with scholars based in Russia, United States and Germany. Frequent co-authors include Dong‐Wook Kim, Jörge E. Cortes, Carlo Gambacorti‐Passerini, Hagop M. Kantarjian, H. Jean Khoury, Tim H. Brümmendorf, Eric Leip, Steven Arkin, Charles Cunningham and Steven Novick. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.